Incyte (INCY) Inventory (2012 - 2026)
Incyte's (INCY) quarterly Inventory came in at $112.5 million in Q2 2026, up 34.91% YoY from $83.4 million in Q2 2025, and down 2.67% on a QoQ basis from $115.6 million in Q1 2026.
Incyte (INCY) Inventory (2012 - 2026) Analysis & Trends
Incyte (INCY) has 15 years of Inventory data on file, last reported at $112.5 million in Q2 2026.
- Quarterly Inventory rose 34.91% year-over-year to $112.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $112.5 million (up 34.91% YoY) and the FY2025 annual result came in at $101.1 million, up 71.66% from the prior year.
- Inventory fell to $112.5 million in Q2 2026, from $115.6 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $115.6 million in Q1 2026 to a low of $35.5 million in Q1 2022.
- A 5-year average of $68.3 million and a median of $63.3 million in 2023 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory soared 226.36% — and 2023, when it sank 34.06%.
- Tracing INCY's Inventory over 5 years: stood at $42.0 million in 2022, then soared by 49.95% to $63.0 million in 2023, then decreased by 6.51% to $58.9 million in 2024, then surged by 71.66% to $101.1 million in 2025, then grew by 11.36% to $112.5 million in 2026.
- The last three Inventory figures came in at $112.5 million (Q2 2026), $115.6 million (Q1 2026), and $101.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn | 112.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.54 Mn |
| Mar 31, 2026 | 115.62 Mn |
| Dec 31, 2025 | 101.06 Mn |
| Sep 30, 2025 | 83.45 Mn |
| Jun 30, 2025 | 83.42 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 58.87 Mn |
| Sep 30, 2024 | 70.44 Mn |
| Jun 30, 2024 | 100.70 Mn |
| Mar 31, 2024 | 63.64 Mn |
| Dec 31, 2023 | 62.97 Mn |
| Sep 30, 2023 | 57.20 Mn |
| Jun 30, 2023 | 35.94 Mn |
| Mar 31, 2023 | 40.90 Mn |
| Dec 31, 2022 | 42.00 Mn |
| Sep 30, 2022 | 45.90 Mn |
| Jun 30, 2022 | 54.50 Mn |
| Mar 31, 2022 | 35.50 Mn |
| Dec 31, 2021 | 27.90 Mn |
| Sep 30, 2021 | 21.30 Mn |